195 related articles for article (PubMed ID: 34008252)
21. Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant - a pilot study.
Visseren T; Fuhler GM; Erler NS; Nossent YRA; Metselaar HJ; IJzermans JNM; Darwish Murad S; Peppelenbosch MP
Transpl Int; 2020 Nov; 33(11):1424-1436. PubMed ID: 33617049
[TBL] [Abstract][Full Text] [Related]
22. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
Steenstraten IC; Sebib Korkmaz K; Trivedi PJ; Inderson A; van Hoek B; Rodriguez Girondo MDM; Maljaars PWJ
Aliment Pharmacol Ther; 2019 Mar; 49(6):636-643. PubMed ID: 30740723
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis.
Smolka V; Karaskova E; Tkachyk O; Aiglova K; Ehrmann J; Michalkova K; Konecny M; Volejnikova J
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):412-8. PubMed ID: 27498582
[TBL] [Abstract][Full Text] [Related]
24. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
[TBL] [Abstract][Full Text] [Related]
25. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.
Khettry U; Keaveny A; Goldar-Najafi A; Lewis WD; Pomfret EA; Pomposelli JJ; Jenkins RL; Gordon FD
Hum Pathol; 2003 Nov; 34(11):1127-36. PubMed ID: 14652814
[TBL] [Abstract][Full Text] [Related]
26. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions.
Leung KK; Deeb M; Fischer SE; Gulamhusein A
Semin Liver Dis; 2021 Aug; 41(3):409-420. PubMed ID: 34182588
[TBL] [Abstract][Full Text] [Related]
27. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
Hildebrand T; Pannicke N; Dechene A; Gotthardt DN; Kirchner G; Reiter FP; Sterneck M; Herzer K; Lenzen H; Rupp C; Barg-Hock H; de Leuw P; Teufel A; Zimmer V; Lammert F; Sarrazin C; Spengler U; Rust C; Manns MP; Strassburg CP; Schramm C; Weismüller TJ;
Liver Transpl; 2016 Jan; 22(1):42-52. PubMed ID: 26438008
[TBL] [Abstract][Full Text] [Related]
28. Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry.
Berenguer M; Di Maira T; Baumann U; Mirza DF; Heneghan MA; Klempnauer JL; Bennet W; Ericzon BG; Line PD; Lodge PA; Zieniewicz K; Watson CJE; Metselaar HJ; Adam R; Karam V; Aguilera V;
Transplantation; 2021 Oct; 105(10):2255-2262. PubMed ID: 33196626
[TBL] [Abstract][Full Text] [Related]
29. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
[TBL] [Abstract][Full Text] [Related]
30. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
32. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
Tanaka A; Kono H; Leung PSC; Gershwin ME
Cell Immunol; 2020 Jan; 347():104021. PubMed ID: 31767117
[TBL] [Abstract][Full Text] [Related]
33. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.
Singh H; Balouch F; Noble C; Lewindon P
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284
[TBL] [Abstract][Full Text] [Related]
34. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.
Fosby B; Karlsen TH; Melum E
World J Gastroenterol; 2012 Jan; 18(1):1-15. PubMed ID: 22228965
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.
Liberal R; Vergani D; Mieli-Vergani G
Liver Transpl; 2016 Sep; 22(9):1275-83. PubMed ID: 27257963
[TBL] [Abstract][Full Text] [Related]
36. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
[TBL] [Abstract][Full Text] [Related]
38. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.
Emek E; Serin A; Sahin T; Yazici P; Yuzer Y; Tokat Y; Bozkurt B
Transplant Proc; 2019 Sep; 51(7):2439-2441. PubMed ID: 31405746
[TBL] [Abstract][Full Text] [Related]
39. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
Henson JB; Patel YA; Wilder JM; Zheng J; Chow SC; King LY; Muir AJ
Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
[TBL] [Abstract][Full Text] [Related]
40. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
